1 study on Ac-yvad-cho curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This comparative study provides compelling evidence that caspase-1 inhibition is a highly effective therapeutic strategy for mitigating inflammation and tissue damage in complex multisystem diseases like IBD and NASH.…
Free, no account — handy when you're working with Ac-yvad-cho.